Literature DB >> 18651175

Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence.

Rachel J Smith1, Gary Aston-Jones.   

Abstract

Studies reviewed here implicate the extended amygdala in the negative affective states and increased drug-seeking that occur during protracted abstinence from chronic drug exposure. Norepinephrine (NE) and corticotropin-releasing factor (CRF) signaling in the extended amygdala, including the bed nucleus of the stria terminalis, shell of the nucleus accumbens, and central nucleus of the amygdala, are generally involved in behavioral responses to environmental and internal stressors. Hyperactivity of stress response systems during addiction drives many negative components of drug abstinence. In particular, NE signaling from the nucleus tractus solitarius (NTS) to the extended amygdala, along with increased CRF transmission within the extended amygdala, are critical for the aversiveness of acute opiate withdrawal as well as stress-induced relapse of drug-seeking for opiates, cocaine, ethanol, and nicotine. NE and CRF transmission in the extended amygdala are also implicated in the increased anxiety that occurs during prolonged abstinence from chronic opiates, cocaine, ethanol, and cannabinoids. Many of these stress-associated behaviors are reversed by NE or CRF antagonists given systemically or locally within the extended amygdala. Finally, increased Fos activation in the extended amygdala and NTS is associated with the enhanced preference for drugs and decreased preference for natural rewards observed during protracted abstinence from opiates and cocaine, indicating that these areas are involved in the altered reward processing associated with addiction. Together, these findings suggest that involvement of the extended amygdala and its noradrenergic afferents in anxiety, stress-induced relapse, and altered reward processing reflects a common function for these circuits in stress modulation of drug-seeking.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651175      PMCID: PMC3632504          DOI: 10.1007/s00429-008-0191-3

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  206 in total

Review 1.  The role of the striatopallidal and extended amygdala systems in drug addiction.

Authors:  G F Koob
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

2.  Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.

Authors:  Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 3.  New strategies in the search for anxiolytics.

Authors:  S E File
Journal:  Drug Des Deliv       Date:  1990-03

4.  Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal.

Authors:  G C Harris; G Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2001-01       Impact factor: 7.853

5.  A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking.

Authors:  S Erb; J Stewart
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

6.  Mesolimbic dopaminergic decline after cannabinoid withdrawal.

Authors:  M Diana; M Melis; A L Muntoni; G L Gessa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

8.  The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat.

Authors:  S Rassnick; L Stinus; G F Koob
Journal:  Brain Res       Date:  1993-09-24       Impact factor: 3.252

9.  Opiocortin and catecholamine input to CRF-immunoreactive neurons in rat forebrain.

Authors:  P J Hornby; D T Piekut
Journal:  Peptides       Date:  1989 Nov-Dec       Impact factor: 3.750

10.  Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress.

Authors:  Marco Cecchi; Habibeh Khoshbouei; David A Morilak
Journal:  Neuropharmacology       Date:  2002-12       Impact factor: 5.250

View more
  110 in total

1.  Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference.

Authors:  A González-Cuello; L Mora; J M Hidalgo; N Meca; C Lasheras; M V Milanés; M L Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-06       Impact factor: 3.000

2.  Alcohol stress response dampening: selective reduction of anxiety in the face of uncertain threat.

Authors:  Kathryn R Hefner; John J Curtin
Journal:  J Psychopharmacol       Date:  2011-09-21       Impact factor: 4.153

3.  CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.

Authors:  Javier Navarro-Zaragoza; Cristina Núñez; Jessica Ruiz-Medina; M Luisa Laorden; Olga Valverde; M Victoria Milanés
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 4.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

Review 5.  Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.

Authors:  Ana Franky Carvalho; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-24       Impact factor: 5.067

6.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

Review 7.  Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions.

Authors:  Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-20       Impact factor: 3.619

8.  Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors.

Authors:  John R Mantsch; Andy Weyer; Oliver Vranjkovic; Chad E Beyer; David A Baker; Holly Caretta
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

9.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

10.  The effects of medial prefrontal cortex infusions of cocaine in a runway model of drug self-administration: evidence of reinforcing but not anxiogenic actions.

Authors:  Daniel Guzman; Justin M Moscarello; Aaron Ettenberg
Journal:  Eur J Pharmacol       Date:  2009-01-10       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.